[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

James et al., 1988 - Google Patents

Protein heterogeneity of lipoprotein particles containing apolipoprotein AI without apolipoprotein A-II and apolipoprotein AI with apolipoprotein A-II isolated from …

James et al., 1988

View HTML
Document ID
5898427052684880086
Author
James R
Hochstrasser D
Tissot J
Funk M
Appel R
Barja F
Pellegrini C
Muller A
Pometta D
Publication year
Publication venue
Journal of Lipid Research

External Links

Snippet

The protein heterogeneity of fractions isolated by immunoaffinity chromatography on anti- apolipoprotein AI and anti-apolipoprotein A-II affinity columns was analyzed by high resolution two-dimensional gel electrophoresis. The two-dimensional gel electrophoresis …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/558—Immunoassay; Biospecific binding assay using diffusion or migration of antigen or antibody
    • G01N33/561—Immunoelectrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides

Similar Documents

Publication Publication Date Title
James et al. Protein heterogeneity of lipoprotein particles containing apolipoprotein AI without apolipoprotein A-II and apolipoprotein AI with apolipoprotein A-II isolated from human plasma.
Ishida et al. Prebeta-migrating high density lipoprotein: quantitation in normal and hyperlipidemic plasma by solid phase radioimmunoassay following electrophoretic transfer.
Weisgraber et al. Subfractionation of human high density lipoproteins by heparin-Sepharose affinity chromatography.
Havekes et al. A rapid micromethod for apolipoprotein E phenotyping directly in serum
Chapman et al. A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum.
Alaupovic et al. Isolation and characterization of an apoA-II-containing lipoprotein (LP-A-II: B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemia.
DE3783991T2 (en) TEST METHOD AND DIAGNOSTIC SYSTEM FOR DETERMINING THE ABNORMAL FATI-METABOLISM.
JPS63159398A (en) Hybrid and monoclonal paratopic molecule to apolipoprotein a-i
JPH0688823A (en) Measuring method for phospholipid and its antibody
Morton et al. Regulation of lipid transfer between lipoproteins by an endogenous plasma protein: selective inhibition among lipoprotein classes.
Dashti et al. Identification and partial characterization of discrete apolipoprotein B containing lipoprotein particles produced by human hepatoma cell line HepG2
Herbert et al. Apolipoprotein B-100 deficiency. Intestinal steatosis despite apolipoprotein B-48 synthesis.
Tikkanen et al. Differential reactivity of human low density lipoproteins with monoclonal antibodies.
Soutar et al. The characterization of lipoproteins in the high density fraction obtained from patients with familial lecithin: cholesterol acyltransferase deficiency and their interaction with cultured human fibroblasts.
PT85490B (en) HIBRIDEMAS PRODUCERS OF APOLIPOPROTEIN - B SPECIFIC MONOCLONAL ANTIBODIES AND TEST PROCESSES FOR THE DETERMINATION OF THE REFERENCE APOLIPOPROTEIN
Kandoussi et al. Quantitative determination of different apolipoprotein B containing lipoproteins by an enzyme linked immunosorbent assay: apo B with apo C-III and apo B with apo E
Koren et al. Characterization of a monoclonal antibody that binds equally to all apolipoprotein and lipoprotein forms of human plasma apolipoprotein BI Specificity and binding studies
Krimbou et al. Association of apolipoprotein E with α2-macroglobulin in human plasma
Gries et al. Interaction of LDL, Lp [a], and reduced Lp [a] with monoclonal antibodies against apoB.
Guo et al. Characterization of five mouse monoclonal antibodies to apolipoprotein [a] from human Lp [a]: evidence for weak plasminogen reactivity.
Lagrost Determination of the mass concentration and the activity of the plasma cholesteryl ester transfer protein (CETP)
Moskowitz et al. Epidermal growth factor precursor is present in a variety of human renal cyst fluids
O'Connor et al. Measurement of prebeta-1 HDL in human plasma by an ultrafiltration-isotope dilution technique
Marcel et al. High density lipoprotein subfractions isolated by heparin-Sepharose affinity chromatography and their role in cholesteryl ester transfer to very low density lipoproteins.
Koren et al. Selective isolation of human plasma low-density lipoprotein particles containing apolipoproteins B and E by use of a monoclonal antibody to apolipoprotein B